| Financial Year |
March 31 2023 |
| Monetary Funds |
7,140,623,996.51 |
| Held-for-trading Financial Assets |
694,661,323.24 |
| Notes Receivable |
-- |
| Accounts Receivable |
33,252,788.71 |
| Advances to Suppliers |
3,615,779,590.88 |
| Other Receivables |
69,524,605.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,332,001,475.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,030,000,000.00 |
| Other Current Assets |
607,254,017.84 |
| Total Current Assets |
21,125,515,219.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
429,987,093.55 |
| Investment Properties |
90,239,731.48 |
| Fixed Assetes |
20,356,801,697.93 |
| Under-construction Projects |
3,201,994,594.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,532,476,601.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
841,500.00 |
| Deferred Income Tax Assets |
351,908,802.95 |
| Other Non-Current Assets |
1,303,483,048.64 |
| Sub-Total of Non-Current Assets |
27,847,037,448.03 |
| Total Assets |
48,972,552,667.86 |
| Short-Term Loans |
9,502,021,377.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,976,480,646.49 |
| Accounts Payable |
4,053,599,016.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
151,547,192.01 |
| Taxes Payable |
71,526,484.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
751,261,710.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,165,721,427.69 |
| Other Current Liabilities |
84,341,448.96 |
| Sub-Total of Current Liabilities |
25,413,526,089.04 |
| Long-term Loans |
1,626,248,291.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,443,201.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,220,801,030.42 |
| Total Liabilities |
27,634,327,119.46 |
| Paid-In Capital(Or Share Stock) |
2,451,576,238.00 |
| Capital Surplus |
3,988,284,840.44 |
| Surplus Reserve |
1,374,881,652.15 |
| LESS:Treasury Stock |
151,507,443.95 |
| Undistributed Profits |
13,806,890,434.59 |
| Minority Stockholder's Interest |
121,652,813.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,216,572,734.52 |
| Owner's Equity（Stockholder's Equity） |
21,338,225,548.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,972,552,667.86 |
